COVID-19

News

Regeneron's antibody cocktail cuts COVID hospitalisation in ...

Regeneron has posted findings from a large trial of its COVID-19 antibody cocktail showing the therapy reduced risk of hospitalisation or death by 70%.

News

AI drug discovery player 1910 Genetics debuts with $26m war ...

There's a new kid on the block among companies using artificial intelligence in drug discovery, after 1910 Genetics launched today with $26 million in financing.

Digital

Health tech and digital transformation lessons from the NHS

In the year since the UK went into its first lockdown to limit the spread of COVID-19 the country’s health service has undergone an unprecedented digital transformation.

News

Boehringer Ingelheim, Biberach, Germany, February 2007

COVID-19 drives Boehringer's R&D spend to record level in 20...

Boehringer Ingelheim invested €3.7 billion on R&D last year, the highest spend in its history, as it mobilised its scientists to seek out new therapies for COVID-19.

Partner Content